La Jolla’s Innovus Pharmaceuticals Inc., a commercial-stage drug company that makes over-the-counter medicine, has acquired Austin, Texas-based Beyond Human for $630,000 in cash.
San Diego skin care firm MDRejuvena Inc. has appointed Randy Kriech as president and CEO of the company.
These are uneasy days for biotech CFOs. Valuations are down, capital is harder to come by, and companies (fearful they will be undervalued) are shying away from acquisition talks.
One of San Diego County’s biggest drugmakers is teaming up with a cancer center in Texas to tackle new strategies in oncology.
BIOTECH: Key Resource Offered in Co.’s Lab Rentals
Two entrepreneurs in San Diego are applying “sharing economy” principles to a new frontier: science.
San Diego-based OncoSec Medical Inc. will sell about $10 million of its common stock to a single health care institutional fund, the company announced Monday.
San Diego Venture Group is giving dozens of local startups a stage to show off their tech at its yearly “Cool Companies” event in early June. Shortly after the event, the startups will get private meetings with over 30 venture capitalists visiting from Silicon Valley and Los Angeles.
Avalon Ventures is launching an additional startup out of its VC incubator in La Jolla. The firm, called PDI Therapeutics Inc., is jointly backed by British drugmaker GlaxoSmithKline and San Diego’s Avalon as part of an ongoing partnership.
Avalon Ventures is launching yet another startup out of its VC incubator in La Jolla. The firm, called PDI Therapeutics Inc., is jointly backed by British drugmaker GlaxoSmithKline and San Diego’s Avalon as part of an ongoing partnership.
Bioinformatics firm Edico Genome Corp. has landed its third foundational patent, the company announced Thursday. The patent further secures the company’s core technology, and may ease the minds of collaborators considering new applications for the tech.